AnaptysBio Inc (ANAB)
26.48
-0.10
(-0.38%)
USD |
NASDAQ |
May 06, 12:12
AnaptysBio Cash and Short Term Investments (Quarterly): 390.90M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 390.90M |
| September 30, 2023 | 413.05M |
| June 30, 2023 | 429.49M |
| March 31, 2023 | 431.15M |
| December 31, 2022 | 441.24M |
| September 30, 2022 | 442.97M |
| June 30, 2022 | 442.15M |
| March 31, 2022 | 505.62M |
| December 31, 2021 | 548.10M |
| September 30, 2021 | 374.06M |
| June 30, 2021 | 390.85M |
| March 31, 2021 | 380.36M |
| December 31, 2020 | 393.65M |
| September 30, 2020 | 338.35M |
| June 30, 2020 | 377.88M |
| March 31, 2020 | 362.48M |
| December 31, 2019 | 374.23M |
| September 30, 2019 | 421.00M |
| Date | Value |
|---|---|
| June 30, 2019 | 422.22M |
| March 31, 2019 | 415.66M |
| December 31, 2018 | 427.08M |
| September 30, 2018 | 493.81M |
| June 30, 2018 | 267.91M |
| March 31, 2018 | 248.16M |
| December 31, 2017 | 248.41M |
| September 30, 2017 | 115.72M |
| June 30, 2017 | 106.36M |
| March 31, 2017 | 103.50M |
| December 31, 2016 | 51.23M |
| September 30, 2016 | 47.13M |
| June 30, 2016 | 50.59M |
| March 31, 2016 | 49.32M |
| December 31, 2015 | 51.68M |
| September 30, 2015 | 55.24M |
| June 30, 2015 | 16.89M |
| December 31, 2014 | 22.19M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
338.35M
Minimum
Sep 2020
548.10M
Maximum
Dec 2021
414.72M
Average
413.05M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| XOMA Corp | 153.45M |
| Fate Therapeutics Inc | 315.18M |
| Ocular Therapeutix Inc | 195.81M |
| Apellis Pharmaceuticals Inc | 351.18M |
| Sutro Biopharma Inc | 375.62M |